Future Market Insights opines the Microbial Coagulants Market is entering a consolidation-driven technology transition, where the Novonesis merger between Novozymes and Chr. Hansen is reshaping competitive dynamics and accelerating the replacement of traditional animal rennet with fermentation-derived microbial enzyme systems across global cheese manufacturing.